【醫藥護人員場】活動議程
>>> 往後 10 秒
<<< 往前 10 秒
- 1. Long-term Treatment Outcomes for Patients with Localized Prostate Cancer in Taiwan – Cryoablation (冷凍治療)
- 2. Primary total cryoablation cohort
- 3. Clinicopathological Parameters (Primary Cryo, N=223)
- 4. Disease-Free Survival (Phoenix criteria)(Primary Total Cryo, N=223)
- 5. Disease-Free Survival (Phoenix criteria)(Primary Total Cryo, N=223)
- 6. Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
- 7. Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
- 8. L (2)
- 9. Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
- 10. L (2)
- 11. Effect of Adjuvant ADT on Disease-free survival
- 12. Adjuvant ADT for high risk CaP:Prospective randomized trial
- 13. Outcome: PSA Response
- 14. Overall and Cancer-Specific Survival(Primary Total Cryo, N=223)
- 15. Complications of Cryoablation
- 16. Complications of Cryoablation
- 17. Urinary Incontinence (any pad use)
- 18. Urinary Incontinence (any pad use)
- 19. Urinary Incontinence (any pad use)
- 20. Other Complications (Primary Cryo, N=233)(Grade II)
- 21. Conclusion
- 22. Thank you for your attention!
1/22
- 速度 :
- 畫質 :
00:00/08:38
00:00/00:04
-
00:00
1.
Long-term Treatment Outcomes for Patients with Localized Prostate Cancer in Taiwan – Cryoablation (冷凍治療)
-
00:04
2.
Primary total cryoablation cohort
-
00:48
3.
Clinicopathological Parameters (Primary Cryo, N=223)
-
01:22
4.
Disease-Free Survival (Phoenix criteria)(Primary Total Cryo, N=223)
-
01:51
5.
Disease-Free Survival (Phoenix criteria)(Primary Total Cryo, N=223)
-
02:18
6.
Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
-
02:30
7.
Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
-
02:45
8.
L (2)
-
02:48
9.
Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
-
02:49
10.
L (2)
-
03:19
11.
Effect of Adjuvant ADT on Disease-free survival
-
03:36
12.
Adjuvant ADT for high risk CaP:Prospective randomized trial
-
04:07
13.
Outcome: PSA Response
-
05:10
14.
Overall and Cancer-Specific Survival(Primary Total Cryo, N=223)
-
05:48
15.
Complications of Cryoablation
-
06:34
16.
Complications of Cryoablation
-
06:49
17.
Urinary Incontinence (any pad use)
-
07:01
18.
Urinary Incontinence (any pad use)
-
07:25
19.
Urinary Incontinence (any pad use)
-
07:26
20.
Other Complications (Primary Cryo, N=233)(Grade II)
-
08:05
21.
Conclusion
-
08:29
22.
Thank you for your attention!
- 索引
- 筆記
- 全螢幕
【醫藥護人員場】9. Long-term Treatment Outcomes for Localized Prostate Cancer by Risk Group Stratification in Taiwan-冷凍治療
長度: 08:38, 瀏覽: 1137, 最近修訂: 2017-05-09
-
00:00
1.
Long-term Treatment Outcomes for Patients with Localized Prostate Cancer in Taiwan – Cryoablation (冷凍治療)
-
00:04
2.
Primary total cryoablation cohort
-
00:48
3.
Clinicopathological Parameters (Primary Cryo, N=223)
-
01:22
4.
Disease-Free Survival (Phoenix criteria)(Primary Total Cryo, N=223)
-
01:51
5.
Disease-Free Survival (Phoenix criteria)(Primary Total Cryo, N=223)
-
02:18
6.
Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
-
02:30
7.
Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
-
02:45
8.
L (2)
-
02:48
9.
Disease-Free Survival (Phoenix criteria)NTUH v.s. COLD
-
02:49
10.
L (2)
-
03:19
11.
Effect of Adjuvant ADT on Disease-free survival
-
03:36
12.
Adjuvant ADT for high risk CaP:Prospective randomized trial
-
04:07
13.
Outcome: PSA Response
-
05:10
14.
Overall and Cancer-Specific Survival(Primary Total Cryo, N=223)
-
05:48
15.
Complications of Cryoablation
-
06:34
16.
Complications of Cryoablation
-
06:49
17.
Urinary Incontinence (any pad use)
-
07:01
18.
Urinary Incontinence (any pad use)
-
07:25
19.
Urinary Incontinence (any pad use)
-
07:26
20.
Other Complications (Primary Cryo, N=233)(Grade II)
-
08:05
21.
Conclusion
-
08:29
22.
Thank you for your attention!
- 位置
-
- 資料夾名稱
- 2016臺大攝護祭-醫藥護人員場
- 發表人
- 系統管理者
- 單位
- 泌尿部
- 建立
- 2016-05-10 12:32:00
- 最近修訂
- 2017-05-09 09:59:11
- 長度
- 08:38